78 related articles for article (PubMed ID: 24747660)
1. Novel ethological endophenotypes in a transgenic mouse model of Huntington's disease.
Mo C; Renoir T; Hannan AJ
Behav Brain Res; 2015 Jan; 276():17-27. PubMed ID: 24747660
[TBL] [Abstract][Full Text] [Related]
2. Ethological endophenotypes are altered by elevated stress hormone levels in both Huntington's disease and wildtype mice.
Mo C; Renoir T; Hannan AJ
Behav Brain Res; 2014 Nov; 274():118-27. PubMed ID: 25101541
[TBL] [Abstract][Full Text] [Related]
3. Effects of chronic stress on the onset and progression of Huntington's disease in transgenic mice.
Mo C; Renoir T; Hannan AJ
Neurobiol Dis; 2014 Nov; 71():81-94. PubMed ID: 25088714
[TBL] [Abstract][Full Text] [Related]
4. The influence of the HPG axis on stress response and depressive-like behaviour in a transgenic mouse model of Huntington's disease.
Du X; Pang TY; Mo C; Renoir T; Wright DJ; Hannan AJ
Exp Neurol; 2015 Jan; 263():63-71. PubMed ID: 25246229
[TBL] [Abstract][Full Text] [Related]
5. Early retinal function deficit without prominent morphological changes in the R6/2 mouse model of Huntington's disease.
Ragauskas S; Leinonen H; Puranen J; Rönkkö S; Nymark S; Gurevicius K; Lipponen A; Kontkanen O; Puoliväli J; Tanila H; Kalesnykas G
PLoS One; 2014; 9(12):e113317. PubMed ID: 25469887
[TBL] [Abstract][Full Text] [Related]
6. Cognitive deficits in transgenic and knock-in HTT mice parallel those in Huntington's disease.
Farrar AM; Murphy CA; Paterson NE; Oakeshott S; He D; Alosio W; McConnell K; Menalled LB; Ramboz S; Park LC; Howland D; Brunner D
J Huntingtons Dis; 2014; 3(2):145-58. PubMed ID: 25062858
[TBL] [Abstract][Full Text] [Related]
7. Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease.
Dorner JL; Miller BR; Barton SJ; Brock TJ; Rebec GV
Behav Brain Res; 2007 Mar; 178(1):90-7. PubMed ID: 17239451
[TBL] [Abstract][Full Text] [Related]
8. Progressive sleep and electroencephalogram changes in mice carrying the Huntington's disease mutation.
Kantor S; Szabo L; Varga J; Cuesta M; Morton AJ
Brain; 2013 Jul; 136(Pt 7):2147-58. PubMed ID: 23801737
[TBL] [Abstract][Full Text] [Related]
9. Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington's disease.
Ferrante A; Martire A; Pepponi R; Varani K; Vincenzi F; Ferraro L; Beggiato S; Tebano MT; Popoli P
Neurobiol Dis; 2014 Nov; 71():193-204. PubMed ID: 25132555
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal analysis of the electroencephalogram and sleep phenotype in the R6/2 mouse model of Huntington's disease.
Fisher SP; Black SW; Schwartz MD; Wilk AJ; Chen TM; Lincoln WU; Liu HW; Kilduff TS; Morairty SR
Brain; 2013 Jul; 136(Pt 7):2159-72. PubMed ID: 23801738
[TBL] [Abstract][Full Text] [Related]
11. Animal models of Huntington's disease: implications in uncovering pathogenic mechanisms and developing therapies.
Wang LH; Qin ZH
Acta Pharmacol Sin; 2006 Oct; 27(10):1287-302. PubMed ID: 17007735
[TBL] [Abstract][Full Text] [Related]
12. Reduced expression of PSA-NCAM in the hippocampus and piriform cortex of the R6/1 and R6/2 mouse models of Huntington's disease.
van der Borght K; Brundin P
Exp Neurol; 2007 Mar; 204(1):473-8. PubMed ID: 17187781
[TBL] [Abstract][Full Text] [Related]
13. Depletion of rabphilin 3A in a transgenic mouse model (R6/1) of Huntington's disease, a possible culprit in synaptic dysfunction.
Smith R; Petersén A; Bates GP; Brundin P; Li JY
Neurobiol Dis; 2005 Dec; 20(3):673-84. PubMed ID: 15967669
[TBL] [Abstract][Full Text] [Related]
14. Physical activity fails to rescue hippocampal neurogenesis deficits in the R6/2 mouse model of Huntington's disease.
Kohl Z; Kandasamy M; Winner B; Aigner R; Gross C; Couillard-Despres S; Bogdahn U; Aigner L; Winkler J
Brain Res; 2007 Jun; 1155():24-33. PubMed ID: 17512917
[TBL] [Abstract][Full Text] [Related]
15. Weight loss in Huntington disease increases with higher CAG repeat number.
Aziz NA; van der Burg JM; Landwehrmeyer GB; Brundin P; Stijnen T; ; Roos RA
Neurology; 2008 Nov; 71(19):1506-13. PubMed ID: 18981372
[TBL] [Abstract][Full Text] [Related]
16. Alterations in N-methyl-D-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6/2 mouse model of Huntington's disease.
Starling AJ; André VM; Cepeda C; de Lima M; Chandler SH; Levine MS
J Neurosci Res; 2005 Nov; 82(3):377-86. PubMed ID: 16211559
[TBL] [Abstract][Full Text] [Related]
17. Wheel running and environmental enrichment differentially modify exon-specific BDNF expression in the hippocampus of wild-type and pre-motor symptomatic male and female Huntington's disease mice.
Zajac MS; Pang TY; Wong N; Weinrich B; Leang LS; Craig JM; Saffery R; Hannan AJ
Hippocampus; 2010 May; 20(5):621-36. PubMed ID: 19499586
[TBL] [Abstract][Full Text] [Related]
18. Olfactory abnormalities in Huntington's disease: decreased plasticity in the primary olfactory cortex of R6/1 transgenic mice and reduced olfactory discrimination in patients.
Lazic SE; Goodman AO; Grote HE; Blakemore C; Morton AJ; Hannan AJ; van Dellen A; Barker RA
Brain Res; 2007 Jun; 1151():219-26. PubMed ID: 17400200
[TBL] [Abstract][Full Text] [Related]
19. Early behavioral deficits in R6/2 mice suitable for use in preclinical drug testing.
Hickey MA; Gallant K; Gross GG; Levine MS; Chesselet MF
Neurobiol Dis; 2005 Oct; 20(1):1-11. PubMed ID: 16137562
[TBL] [Abstract][Full Text] [Related]
20. An open system for automatic home-cage behavioral analysis and its application to male and female mouse models of Huntington's disease.
Zarringhalam K; Ka M; Kook YH; Terranova JI; Suh Y; King OD; Um M
Behav Brain Res; 2012 Apr; 229(1):216-25. PubMed ID: 22266926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
